These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
159 related articles for article (PubMed ID: 19388022)
1. Activation of the West Nile virus NS3 protease: molecular dynamics evidence for a conformational selection mechanism. Ekonomiuk D; Caflisch A Protein Sci; 2009 May; 18(5):1003-11. PubMed ID: 19388022 [TBL] [Abstract][Full Text] [Related]
2. Structural basis for the activation of flaviviral NS3 proteases from dengue and West Nile virus. Erbel P; Schiering N; D'Arcy A; Renatus M; Kroemer M; Lim SP; Yin Z; Keller TH; Vasudevan SG; Hommel U Nat Struct Mol Biol; 2006 Apr; 13(4):372-3. PubMed ID: 16532006 [TBL] [Abstract][Full Text] [Related]
3. Homology modeling and molecular dynamics study of West Nile virus NS3 protease: a molecular basis for the catalytic activity increased by the NS2B cofactor. Zhou H; Singh NJ; Kim KS Proteins; 2006 Nov; 65(3):692-701. PubMed ID: 16972281 [TBL] [Abstract][Full Text] [Related]
4. MD simulations reveal alternate conformations of the oxyanion hole in the Zika virus NS2B/NS3 protease. Ren J; Lee H; Kotak A; Johnson ME Proteins; 2020 Feb; 88(2):345-354. PubMed ID: 31461176 [TBL] [Abstract][Full Text] [Related]
5. Structure-based mutagenesis identifies important novel determinants of the NS2B cofactor of the West Nile virus two-component NS2B-NS3 proteinase. Radichev I; Shiryaev SA; Aleshin AE; Ratnikov BI; Smith JW; Liddington RC; Strongin AY J Gen Virol; 2008 Mar; 89(Pt 3):636-641. PubMed ID: 18272753 [TBL] [Abstract][Full Text] [Related]
6. NMR analysis of the dynamic exchange of the NS2B cofactor between open and closed conformations of the West Nile virus NS2B-NS3 protease. Su XC; Ozawa K; Qi R; Vasudevan SG; Lim SP; Otting G PLoS Negl Trop Dis; 2009 Dec; 3(12):e561. PubMed ID: 19997625 [TBL] [Abstract][Full Text] [Related]
7. Virtual ligand screening of the National Cancer Institute (NCI) compound library leads to the allosteric inhibitory scaffolds of the West Nile Virus NS3 proteinase. Shiryaev SA; Cheltsov AV; Gawlik K; Ratnikov BI; Strongin AY Assay Drug Dev Technol; 2011 Feb; 9(1):69-78. PubMed ID: 21050032 [TBL] [Abstract][Full Text] [Related]
8. Profiling of flaviviral NS2B-NS3 protease specificity provides a structural basis for the development of selective chemical tools that differentiate Dengue from Zika and West Nile viruses. Rut W; Groborz K; Zhang L; Modrzycka S; Poreba M; Hilgenfeld R; Drag M Antiviral Res; 2020 Mar; 175():104731. PubMed ID: 32014497 [TBL] [Abstract][Full Text] [Related]
9. West Nile Virus NS2B/NS3 protease as an antiviral target. Chappell KJ; Stoermer MJ; Fairlie DP; Young PR Curr Med Chem; 2008; 15(27):2771-84. PubMed ID: 18991636 [TBL] [Abstract][Full Text] [Related]
10. Intrinsic flexibility of West Nile virus protease in solution characterized using small-angle X-ray scattering. Garces AP; Watowich SJ Biochemistry; 2013 Oct; 52(39):6856-65. PubMed ID: 24015950 [TBL] [Abstract][Full Text] [Related]
11. Mechanism of NS2B-mediated activation of NS3pro in dengue virus: molecular dynamics simulations and bioassays. Zuo Z; Liew OW; Chen G; Chong PC; Lee SH; Chen K; Jiang H; Puah CM; Zhu W J Virol; 2009 Jan; 83(2):1060-70. PubMed ID: 18971276 [TBL] [Abstract][Full Text] [Related]
12. NMR and MD Studies Reveal That the Isolated Dengue NS3 Protease Is an Intrinsically Disordered Chymotrypsin Fold Which Absolutely Requests NS2B for Correct Folding and Functional Dynamics. Gupta G; Lim L; Song J PLoS One; 2015; 10(8):e0134823. PubMed ID: 26258523 [TBL] [Abstract][Full Text] [Related]
13. Expression and purification of a two-component flaviviral proteinase resistant to autocleavage at the NS2B-NS3 junction region. Shiryaev SA; Aleshin AE; Ratnikov BI; Smith JW; Liddington RC; Strongin AY Protein Expr Purif; 2007 Apr; 52(2):334-9. PubMed ID: 17189703 [TBL] [Abstract][Full Text] [Related]
14. The two-component NS2B-NS3 proteinase represses DNA unwinding activity of the West Nile virus NS3 helicase. Chernov AV; Shiryaev SA; Aleshin AE; Ratnikov BI; Smith JW; Liddington RC; Strongin AY J Biol Chem; 2008 Jun; 283(25):17270-8. PubMed ID: 18442976 [TBL] [Abstract][Full Text] [Related]
15. Mutagenesis of D80-82 and G83 residues in West Nile Virus NS2B: effects on NS2B-NS3 activity and viral replication. Jia F; Fan J; Zhang B; Yuan Z Virol Sin; 2013 Feb; 28(1):16-23. PubMed ID: 23325418 [TBL] [Abstract][Full Text] [Related]
16. Binding specificity of polypeptide substrates in NS2B/NS3pro serine protease of dengue virus type 2: A molecular dynamics Study. Yotmanee P; Rungrotmongkol T; Wichapong K; Choi SB; Wahab HA; Kungwan N; Hannongbua S J Mol Graph Model; 2015 Jul; 60():24-33. PubMed ID: 26086900 [TBL] [Abstract][Full Text] [Related]
17. Switching the substrate specificity of the two-component NS2B-NS3 flavivirus proteinase by structure-based mutagenesis. Shiryaev SA; Ratnikov BI; Aleshin AE; Kozlov IA; Nelson NA; Lebl M; Smith JW; Liddington RC; Strongin AY J Virol; 2007 May; 81(9):4501-9. PubMed ID: 17301157 [TBL] [Abstract][Full Text] [Related]
18. Binding of low molecular weight inhibitors promotes large conformational changes in the dengue virus NS2B-NS3 protease: fold analysis by pseudocontact shifts. de la Cruz L; Nguyen TH; Ozawa K; Shin J; Graham B; Huber T; Otting G J Am Chem Soc; 2011 Nov; 133(47):19205-15. PubMed ID: 22007671 [TBL] [Abstract][Full Text] [Related]
19. Structure of West Nile virus NS3 protease: ligand stabilization of the catalytic conformation. Robin G; Chappell K; Stoermer MJ; Hu SH; Young PR; Fairlie DP; Martin JL J Mol Biol; 2009 Feb; 385(5):1568-77. PubMed ID: 19059417 [TBL] [Abstract][Full Text] [Related]
20. Identification of a novel inhibitor of dengue virus protease through use of a virtual screening drug discovery Web portal. Viswanathan U; Tomlinson SM; Fonner JM; Mock SA; Watowich SJ J Chem Inf Model; 2014 Oct; 54(10):2816-25. PubMed ID: 25263519 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]